Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $85 at Oppenheimer
Tweet
Share
E-mail
Get Alerts HRMY Hot Sheet
Price: $38.08 -0.47%
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 20 | New: 69
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 20 | New: 69
Join SI Premium – FREE
Oppenheimer analyst Andreas Argyrides raised the price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) to $85.00 (from $72.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lantronix, Inc. (LTRX) PT Raised to $11 at Canaccord
- BMO Capital Starts Align Technology (ALGN) at Outperform
- Goldman Sachs Upgrades Cinemark Holdings (CNK) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
